Stockwell Lynn
- SEC CIK
- 0001927032
No open-market purchases or sales filed in the past year.
Current role at each company
- DMII Drugs Made In America Acquisition II Corp.CEO and Exe. Chair of Boardas of Oct 1, 2025
- DMAA Drugs Made In America Acquisition Corp.CEO and Exe. Chair of Boardas of Feb 18, 2025
- BGXX Bright Green CorpDirector, 10% Owneras of Jun 10, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Stockwell Lynn as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DMII Drugs Made In America Acquisition II Corp.
CEO and Exe. Chair of Board3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 (view filing) | Sep 26 | 5 daysLate | Stockwell LynnCEO and Exe. Chair of Board | PPurchase | +700.0K | – | – | +4.9%15.1M after | Duplicate filing |
| Oct 1, 2025 (view filing) | Sep 26 | 5 daysLate | Stockwell LynnCEO and Exe. Chair of Board | SSale | −7.97M | – | – | −54.3%6.71M after | Duplicate filing |
| Oct 1, 2025 (view filing) | Sep 26 | 5 daysLate | Stockwell LynnCEO and Exe. Chair of Board | PPurchase | +70.0K | – | – | –700.0K after | Derivative |
DMAA Drugs Made In America Acquisition Corp.
CEO and Exe. Chair of Board5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 (view filing) | Feb 18 | Same day | Stockwell LynnCEO and Exe. Chair of Board | PPurchase | +30.0K | – | – | +0.7%4.19M after | |
| Feb 18, 2025 (view filing) | Feb 18 | Same day | Stockwell LynnCEO and Exe. Chair of Board | PPurchase | +30.0K | – | – | –430.0K after | Derivative |
| Feb 4, 2025 (view filing) | Jan 29 | 6 daysLate | Stockwell LynnCEO and Executive COB | PPurchase | +400.0K | – | – | New position10.3K after | |
| Feb 4, 2025 (view filing) | Jan 29 | 6 daysLate | Stockwell LynnCEO and Executive COB | SSale | −5.70M | – | – | −57.8%4.16M after | |
| Feb 4, 2025 (view filing) | Jan 29 | 6 daysLate | Stockwell LynnCEO and Executive COB | PPurchase | +400.0K | – | – | –400.0K after | Derivative |
BGXX Bright Green Corp
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2024 (view filing)9:15 AM ET | Jun 5 | 5 daysLate | Stockwell LynnDirector, 10% Owner | SSale | −1.00M | $0.3597 | −$359.7K | −1.4%68.2M after | |
| Sep 6, 2023 (view filing)5:17 PM ET | Aug 31 | 6 daysLate | Stockwell LynnDirector, 10% Owner | SSale | −250.0K | $0.4667 | −$116.7K | −0.4%66.4M after |